|
|
Article: Antares' Product Development Agreement Wins 2007 Innovative Bio-Partnering Award.
- Article from:
- Business Wire
- Article date:
- October 16, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Treating a Significant CNS Disorder
EWING, N.J. -- Antares Pharma, Inc. (Amex:AIS) announced that it has received, along with its partner Jazz Pharmaceuticals Inc., the BioBusiness Network "2007 Innovative Biotech/Biotech Deal of the Year" award for innovation in deal making. Antares and Jazz Pharmaceuticals signed a worldwide product development and license agreement this past July. The product candidate underlying this agreement is being developed to treat a significant CNS disorder and is based on Antares' proprietary ATD[TM] (Advanced Transdermal Delivery) gel system. Jazz Pharmaceuticals will pay Antares upfront and product development milestones in addition ...
Related newspaper, magazine, and journal articles:
|
|
Article: Antares Pharma, Inc. and Ferring Pharmaceuticals ...
PR Newswire;
February 12, 2003 ;
700+ words
...Antares Pharma, Inc. and Ferring Pharmaceuticals ... VISION, Ferring's trade name for Antares Pharma's Medi-Jector VISION(R) device ... access next-generation devices from Antares Pharma to further support the development ...
|
|